These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
729 related articles for article (PubMed ID: 19000643)
1. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193 [TBL] [Abstract][Full Text] [Related]
3. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity. Holla BS; Rao BS; Sarojini BK; Akberali PM Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049 [TBL] [Abstract][Full Text] [Related]
7. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation. Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate. Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495 [TBL] [Abstract][Full Text] [Related]
10. Pyrazoline bearing benzimidazoles: search for anticancer agent. Shaharyar M; Abdullah MM; Bakht MA; Majeed J Eur J Med Chem; 2010 Jan; 45(1):114-9. PubMed ID: 19883957 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents. Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. Ozkay Y; Işikdağ I; Incesu Z; Akalin G Eur J Med Chem; 2010 Aug; 45(8):3320-8. PubMed ID: 20451307 [TBL] [Abstract][Full Text] [Related]